Yüce
Osmaniye, 80000, Turkey (Türkiye)
NCT Number: NCT06617767
Aim: To evaluate the effects of Reiki on subjective well-being, happiness, and some metabolic variables in patients with Type-II diabetes.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Osmaniye, 80000, Turkey (Türkiye)
This study, designed as a randomized controlled trial with a pretest-posttest design, was conducted between September 2022 and August 2023 at the Internal Medicine clinic of Kanuni Sultan Süleyman Training and Research Hospital, Istanbul Provincial Health Directorate. The participants were voluntary individuals who had been diagnosed with Type-II Diabetes Mellitus at least 6 months prior, had a BMI ≥ 25kg/m² (overweight or obese), HbA1c ≥ 6.5%, were following a diabetes-specific diet or using oral antidiabetics, and were neither Reiki practitioners nor instructors. Randomization was used to assign participants to either the Reiki group or the control group. During the pretest, participants were asked to complete the Personal Information Form, the Subjective Well-Being Scale (SWS), and the OXFORD Happiness Scale (OHS). Pre-intervention fasting and postprandial blood glucose levels, HbA1c percentage, body mass index, LDL-HDL/total cholesterol, triglyceride levels, and blood pressure measurements were obtained from the patients' records and documented.The Reiki group received 20 minutes of remote Reiki once a day for 4 consecutive days, while no intervention was applied to the control group. The Subjective Well-Being Scale and OXFORD Happiness Scale were reapplied to both groups at the first and second months following the intervention, and the metabolic values, along with these scales, were measured again in the third month.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The Reiki group received distant Reiki application to their energy centers for 20 minutes, once a day, for 4 consecutive days, by researchers with Reiki Stage II training under the guidance of a researcher with the Usui Reiki Master & Teacher degree.
Time frame: 3 months
The Subjective Well-Being Scale is a measurement tool developed to determine the subjective experiences and vitality levels of individuals in terms of feeling lively, energetic and alert, and is based on individuals providing information about themselves. The seven-item, 7-point Likert-type scale is ranked from 1 (Does not apply to me at all) to 7 (Completely applies to me), and participants are asked to determine the extent to which they agree with the statement in each item. The scores of all items in the scale can be added to obtain the individual's total subjective vitality score. The range of scores on the scale varies between 7 and 49. High scores on the scale indicate that the individual has a high level of subjective vitality.It is expected that the scores that the participants receive from this scale will increase in the final measurement.
Time frame: 3 months
OXFORD Happiness scale is a 29-item, 6-point Likert-type scale (1-I completely disagree, 6-I completely agree) developed to measure happiness. A high score obtained from the scale indicates an increase in the level of happiness. The scale score range varies between 29-174. It is expected that the scores that the participants receive from this scale will increase in the final measurement.
Time frame: 3 months
HbA1c, is the main biomarker used to assess long-term glycaemic control in individuals with diabetes.In the final test, this value was targeted to be below the level recorded in the pre test in Reiki gruop.
Time frame: 3 months
Fasting blood glucose level is the level of glucose in the blood measured after at least 8 hours of overnight fasting.In the final test, this value was targeted to be below the level recorded in the pre test.
Time frame: 3 months
Postprandial blood sugar is the blood sugar level measured 2 hours after food intake (first bite). It should not be over 140 mg/dl.In the final test, this value was targeted to be below the level recorded in the first test.
Time frame: 3 months
The study initially included individuals who were overweight or obese (BMI ≥ 25kg/m²). The aim was to reduce the body mass index of the participants in the Reiki group, measured in the post-test.
Time frame: 3 months
The highest LDL (low density lipoprotein) level in the post-test measurements of individuals in the Reiki group was targeted to be 130 mg/dL.
Time frame: 3 months
The lowest HDL (high density lipoprotein) level in the post-test measurements of individuals in the Reiki group was targeted to be 40 mg/dL for women and 50 mg/dL for men.
Time frame: 3 months
The highest total kolesterol level in the post-test measurements of individuals in the Reiki group was targeted to be 200 mg/dL.
Time frame: 3 months
The highest triglyceride level in the post-test measurements of individuals in the Reiki group was targeted to be 150 mg/dL.
Osmaniye Korkut Ata University
Other
The Effect of Reiki on Subjective Well-being, Happiness, and Some Metabolic Variables in Patients With Type-II Diabetes: Single-blind Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03899883
Diabetes, Diabetes Complications
Aurora, Colorado, United States
View Trial DetailsNCT04190251
Behavior, Chronic Disease
Lausanne, Canton of Vaud, Switzerland
View Trial DetailsNCT00339482
Cardiovascular Diseases, Diabetes Mellitus
Phoenix, Arizona, United States
View Trial DetailsNCT07663682
Diabetes Mellitus, Diabetes Mellitus, Type 2
Taiyuan, Shanxi, China
View Trial Details